• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

NPJ Vaccines . Influenza mRNA vaccine reduces pathogenicity and transmission of A(H5N1) virus in a ferret model

tetano

Editor, Senior Moderator
NPJ Vaccines


. 2025 Nov 29.
doi: 10.1038/s41541-025-01318-3. Online ahead of print. Influenza mRNA vaccine reduces pathogenicity and transmission of A(H5N1) virus in a ferret model

Masato Hatta[SUP] #[/SUP][SUP] 1 [/SUP], Nicole Brock[SUP] #[/SUP][SUP] 1 [/SUP], Teresa Hauguel[SUP] #[/SUP][SUP] 2 [/SUP], Chenchen Feng[SUP] 1 [/SUP], Ying Huang[SUP] 1 [/SUP], Jana M Ritter[SUP] 3 [/SUP], Yasuko Hatta[SUP] 1 [/SUP], Matthew W Keller[SUP] 1 [/SUP], Ivna De Souza[SUP] 2 [/SUP], Jaber Hossain[SUP] 1 [/SUP], Elizabeth A Pusch[SUP] 1 [/SUP], Thomas Rowe[SUP] 1 [/SUP], Herg Zhang[SUP] 2 [/SUP], Liyang Cui[SUP] 2 [/SUP], Sarah O'Leary[SUP] 2 [/SUP], Juan A De La Cruz[SUP] 1 [/SUP], Monique C Johnson[SUP] 1 [/SUP], Jessica A Belser[SUP] 1 [/SUP], Xiangjie Sun[SUP] 1 [/SUP], Jimma Liddell[SUP] 1 [/SUP], Margaret Creech[SUP] 1 4 [/SUP], Joseph R Rouse[SUP] 1 4 [/SUP], Paul Carney[SUP] 1 [/SUP], Jessie Chang[SUP] 1 [/SUP], Michael Currier[SUP] 1 [/SUP], Li Wang[SUP] 1 [/SUP], Marie K Kirby[SUP] 1 [/SUP], Han Di[SUP] 1 [/SUP], John R Barnes[SUP] 5 [/SUP], James Stevens[SUP] 1 [/SUP], Vivien G Dugan[SUP] 1 [/SUP], C Todd Davis[SUP] 1 [/SUP], David E Wentworth[SUP] 1 6 [/SUP], Pirada Suphaphiphat Allen[SUP] 7 [/SUP], Taronna R Maines[SUP] 8 [/SUP], Bin Zhou[SUP] 9 [/SUP]



Affiliations
Free article Abstract

The global spread of highly pathogenic avian influenza A(H5N1) viruses poses a serious pandemic threat. While sustained human-to-human transmission has not occurred, widespread circulation in birds, increased detection in mammals, and occasional human spillovers underscore the need for safe and effective vaccines. We evaluated an H5 mRNA vaccine candidate in ferrets using recent clade 2.3.4.4b A(H5N1) human isolates. Vaccination elicited strong neutralizing antibodies, conferred robust protection against lethal challenge, and significantly reduced viral titers. In a direct contact transmission model, mRNA vaccination decreased virus shedding in inoculated ferrets and reduced onward transmission; it also protected vaccinated contact ferrets from infection following exposure to virus-shedding, unvaccinated ferrets. Additionally, sera from vaccinated animals cross-neutralized clade 2.3.2.1e human viruses to varying degrees, depending on the strain. These findings demonstrate that H5 mRNA vaccination not only protects against disease but also reduces transmission, supporting its potential as a key tool for pandemic preparedness.


 
Back
Top Bottom